ATM inhibition enhances the effectiveness of immune checkpoint blockade treatment in breast cancer by facilitating the cytoplasmic leakage of mtDNA and the activation of the cGAS-STING pathway (Hu M. et al., 2021). The gene discussed is STING1; the disease is breast carcinoma.